Checkpoint Therapeutics, Inc.
CKPTDelisted May 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651407
Checkpoint Therapeutics, Inc. was delisted on May 30, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 84 institutions reported holding it in 13F filings for Q1 2025, worth $137.7M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Checkpoint Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 68 | 3 | 62 | −3 |
| Shares | 10.6M | 671.7K | 10.7M | +839.2K (+8.5%) |
| Value | $34.9M | $2.22M | $33.4M | +$701.7K (+2.1%) |
3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Norges Bank | 268,500 | $835.0K | 0.00% |
| Renaissance Technologies LLC | 226,500 | $704.0K | 0.00% |
| Alps Advisors Inc | 96,944 | $301.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 68,900 | $214.0K | 0.00% |
| Bartlett & Co. LLC | 50,000 | $156.0K | 0.00% |
| Bartlett & Co. Wealth Management LLC | 50,000 | $155.5K | 0.00% |
| Qube Research & Technologies Ltd | 43,444 | $135.0K | 0.00% |
| Jump Financial, LLC | 23,377 | $73.0K | 0.00% |
| Mirabella Financial Services LLP | 21,700 | $67.0K | 0.01% |
| Golden State Equity Partners | 13,100 | $41.0K | 0.02% |
| Level Four Advisory Services, LLC | 10,000 | $31.0K | 0.00% |
| Amplius Wealth Advisors, LLC | 500 | $1.00K | 0.00% |
Sold out (15)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Two Sigma Investments, LP | 299,832 | $989.0K |
| Marshall Wace, LLP | 121,785 | $402.0K |
| Asset Management Corp | 85,750 | $283.0K |
| HRT Financial LP | 75,242 | $248.0K |
| Capstone Investment Advisors, LLC | 17,636 | $58.0K |
| Virtu Financial LLC | 16,723 | $55.0K |
| Walleye Capital LLC | 16,530 | $55.0K |
| Nomura Holdings Inc | 16,100 | $53.0K |
| Occudo Quantitative Strategies LP | 13,234 | $44.0K |
| Jane Street Group, LLC | 12,193 | $40.0K |
| Barclays PLC | 8,216 | $27.0K |
| Tower Research Capital LLC (TRC) | 1,746 | $6.00K |
| Meeder Asset Management Inc | 915 | $3.00K |
| Group One Trading, L.P. | 100 | $0 |
| O'Shaughnessy Asset Management, LLC | 1 | $0 |
Not filed for Q4 2021 yet (3)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Spotlight Asset Group, Inc. | 661,597 | $2.18M |
| Harbor Financial Services, LLC | 10,000 | $33.0K |
| Sonora Investment Management, LLC | 120 | $0 |